BioPharmaTrend
Latest News
All Topics
  • Artificial Intelligence
  • NeuroTech
  • Premium Content
  • Knowledge Center
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Subscribe
Login/Join
back to Directory

Syntekabio

Syntekabio logo

Website
http://syntekabio.com/
Founded
2009
Patents
10
Publications
14

Technologies

AI Companies (Drug Discovery)

Syntekabio is a leading AI-driven drug discovery company that uses machine learning and supercomputing to discover new drugs.

personal genome map genome-based disease

Interviews

Democratizing Early Drug Discovery through Artificial Intelligence: Interview with Syntekabio CEO Jongsun Jung

Posts Mentioning This Company

How to Discover a Preclinical Drug Candidate in Two Years

June 18, 2023  
Recent advances in artificial intelligence (AI) has played a pivotal role in optimizing the small-molecule synthesis, standardization, scalability and CRO-based validation. Despite a dose of skepticism about the growing hype around AI, introducing greater automation to a drug design hypothesis has enabled more effectual searches for various compound characteristics concerning …
Unlocking AI-Driven Drug Discovery: Syntekabio's Supercomputing Approach

How Syntekabio’s Supercomputing Enables AI-driven Drug Discovery

May 17, 2023  
What is "supercomputing"? It refers to processing a massive quantity of complex data-intensive and computation-heavy problems often found in scientific or engineering projects. Using a powerful class of ‘multiple’ computer systems working in parallel, supercomputing is built into an infrastructure that is supporting a vast array of disciplines. From quantum …
Leveraging STB CLOUD for Remote AI-Driven Drug Discovery

The Power of STB CLOUD in Remote AI Drug Discovery

April 27, 2023  
STB CLOUD is Syntekabio’s latest cloud-based, fully automated AI platform. It’s designed for developers to engage in their drug discovery and development processes to find drug candidates easier and faster.

The State of A.I. Drug Discovery and Its Future: Small Molecules, Vaccines, and Antibodies

March 23, 2023  
Artificial intelligence (A.I.) and big data in a synergistic integration have led to promising results in new drug development by drastically reducing cost and time. This trend in the biopharmaceutical market has emerged as a new industry standard as startups—each with distinctive core A.I. algorithm—fiercely compete to capture their global …
#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development
#advertisement
Webinar: AI in Clinical Trials

 

R&D Platform

We address the entire spectrum of drug development. We use the cutting-edge computational biology technologies for novel drug candidate discovery. We also specialize in co-developing novel drug response biomarkers of the existing drug candidates, which allows improvement of likelihood of successful clinical trial, biomarker-driven indication expansion, and enhanced understanding of the drug's mechanism of action.

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
gnews  Google News
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Premium Content
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Membership
  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.